Abnormalities in the IL-6/JAK/STAT3 pathway are also due to expression of a variety of oncogenes, such as Myc and VEGF, reportedly increased in lung cancer and other cancer types [46, 47]. The gene discussed is MYC; the disease is lung carcinoma.